Brief: Lannett Enters Into Distribution Agreement For Dantrolene Capsules

Elite Pharmaceuticals

28/06/2019 11:59

June 28 (Reuters) - Lannett Company Inc  LCI.N :
    * LANNETT ENTERS INTO DISTRIBUTION AGREEMENT FOR DANTROLENE
CAPSULES, COMMENCES PRODUCT LAUNCH
    * LANNETT COMPANY INC - OTHER FINANCIAL TERMS WERE NOT
DISCLOSED.
    * LANNETT COMPANY - WILL PRIMARILY PROVIDE SALES, MARKETING
AND
DISTRIBUTION SUPPORT FOR PRODUCT, FOR WHICH IT WILL RECEIVE A
SHARE OF PROFITS
    * LANNETT - TO PRIMARILY PROVIDE SALES, MARKETING AND
DISTRIBUTION
SUPPORT FOR PRODUCT, FOR WHICH IT WILL RECEIVE A SHARE OF
PROFITS
    * LANNETT COMPANY INC - ENTERED INTO A THREE-YEAR AGREEMENT
WITH
ELITE PHARMACEUTICALS
    * LANNETT - ENTERED 3-YEAR AGREEMENT WITH ELITE
PHARMACEUTICALS TO
BE EXCLUSIVE U.S. DISTRIBUTOR OF A DANTROLENE CAPSULES 25 MG, 50
MG AND 100 MG.

Source text for Eikon:  ID:nPn3zJVWYa 
Further company coverage:  LCI.N 

 ((Reuters.Briefs@thomsonreuters.com;))